Workflow
信息披露
icon
Search documents
芯朋微: 信息披露管理办法(2025年5月)
Zheng Quan Zhi Xing· 2025-05-30 15:22
Core Points - The document outlines the information disclosure management measures for Wuxi Chipeng Microelectronics Co., Ltd, aiming to ensure accurate, complete, and timely disclosure of information to protect shareholders' rights [1][2] - The chairman of the board is designated as the primary responsible person for information disclosure, while the board secretary is responsible for the specific tasks related to this [2][3] - The company must adhere to principles of openness, fairness, and justice in its information disclosure practices [2][3] Information Disclosure Principles - Information disclosure is a continuous responsibility of the company, which must comply with relevant laws and regulations [2][3] - Insider information must not be disclosed or used for trading before it is legally disclosed [2][3] - All disclosed information should be published on the Shanghai Stock Exchange website and other designated media [2][3] Disclosure Content and Standards - The company must disclose any information that could significantly impact investors' decisions, including financial reports and significant events [4][5] - Annual reports must be audited by qualified accounting firms and disclosed within four months after the fiscal year-end [5][6] - The company must issue performance forecasts if it anticipates significant changes in operating results [5][6] Major Events Disclosure - The company is required to disclose major events that could significantly affect its stock price, including legal issues, financial difficulties, and changes in management [6][7] - Disclosure must occur promptly upon the occurrence of significant events or when there are substantial developments [8][9] Information Disclosure Process - The process for drafting, reviewing, and publishing regular reports involves multiple levels of management, including the general manager and the board of directors [11][12] - The board secretary is responsible for coordinating the information disclosure tasks and ensuring compliance with regulations [12][13] Responsibilities and Accountability - The board of directors and senior management are responsible for the accuracy and completeness of disclosed information [15][16] - Any violations of disclosure regulations may lead to administrative or criminal liability for responsible individuals [16][17] Confidentiality and Internal Control - The company must establish internal controls to protect confidential information and prevent insider trading [16][17] - The financial director is responsible for ensuring the accuracy of financial disclosures and compliance with relevant regulations [17][18]
3家A股公司 一家实控人被刑事立案 两家被证监会立案
Zheng Quan Shi Bao· 2025-05-30 15:09
Core Viewpoint - *ST Tianyu's actual controller Yan Chunyu and others have been criminally investigated for suspected fund misappropriation, which may impact the company's operations and reputation in the data security industry [2][4]. Company Overview - *ST Tianyu has been a leading provider of data security products and solutions in China and is a key player in the smart card industry [4]. - The company has faced multiple challenges, including a risk warning on its stock due to previous violations related to guarantees, which were not resolved within the stipulated timeframe [4]. Recent Developments - The company announced that Yan Chunyu does not hold any director, supervisor, or senior management positions, indicating that the investigation may not significantly affect normal operations [4]. - There have been multiple resignations of key personnel in May, including the chairman and other board members, which may indicate instability within the company [5][8]. Financial Performance - In the 2024 annual report, *ST Tianyu reported total revenue of 847 million yuan, a decrease of 50.20% year-on-year, and a net loss attributable to shareholders of 364 million yuan, compared to a profit of 1.97 million yuan in the previous year [6]. - The 2025 Q1 report showed total revenue of 45.37 million yuan, a decline of 86.50% year-on-year, with a net loss of 40.19 million yuan, compared to a profit of 4.74 million yuan in the same period last year [6].
兖矿能源: 兖矿能源集团股份有限公司第九届董事会第十七次会议决议公告
Zheng Quan Zhi Xing· 2025-05-30 11:43
Group 1 - The board of directors of Yanzhou Coal Mining Company Limited held its 17th meeting on May 30, 2025, with all 11 directors present, confirming compliance with legal and regulatory requirements [1] - The board approved the adjustment of the specialized committee members, replacing Mr. Hu Jiadong with Ms. Rui as a committee member, with unanimous support from all directors present [1][4] - The board approved an internal loan of 1 billion yuan from Shandong Energy Group Luxi Mining Co., Ltd. to its subsidiary, Heze Coal Power Co., Ltd., for a term of 3 years at an interest rate of 3.1%, with asset collateral provided [2][3]
中交设计: 中交设计咨询集团股份有限公司信息披露及重大信息内部报告管理办法
Zheng Quan Zhi Xing· 2025-05-30 11:20
Core Points - The document outlines the information disclosure management measures of China Communications Design Consulting Group Co., Ltd. to enhance the quality and level of information disclosure and protect the rights of the company and its investors [1][2]. Group 1: General Principles - The information disclosure obligations apply to the company, its directors, senior management, shareholders, and other relevant parties involved in significant transactions or changes [2][3]. - Information disclosed must be timely, truthful, accurate, complete, and clear, without misleading statements or omissions [3][4]. - The company must ensure that all investors receive the same information simultaneously, with exceptions only as required by law [4][5]. Group 2: Disclosure Content - Regular reports include annual and semi-annual reports, which must be completed and disclosed within specified timeframes [5][6]. - Annual reports must contain essential company information, financial data, stock and bond issuance details, and significant events affecting the company [6][7]. - The company must disclose any risks that could significantly impact its core competitiveness and future development [6][8]. Group 3: Temporary Reports - Temporary reports are required for significant events that could impact the company's stock price, including major lawsuits, asset impairments, or changes in control [9][10]. - The company must disclose any major changes in its operations or financial performance promptly [10][11]. Group 4: Internal Reporting Mechanism - The internal reporting mechanism for significant information includes immediate reporting to the board of directors upon knowledge of major events [16][17]. - The board secretary is responsible for coordinating and organizing the company's information disclosure work [28][29]. Group 5: Responsibilities and Accountability - The board of directors is responsible for overseeing the information disclosure process, and the chairman is the primary responsible person [28][30]. - Any violations of the disclosure regulations may lead to disciplinary actions against responsible individuals, including potential legal consequences [48][49].
沃格光电: 江西沃格光电集团股份有限公司关于最近五年被证券监管部门和交易所处罚或采取监管措施的公告
Zheng Quan Zhi Xing· 2025-05-30 10:41
证券代码:603773 证券简称:沃格光电 公告编号:2025-041 江西沃格光电集团股份有限公司 关于最近五年被证券监管部门和证券交易所处罚或采取监 管措施情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 江西沃格光电集团股份有限公司(以下简称"公司")拟实施 2025 年度向 特定对象发行 A 股股票项目,现根据相关法律法规要求,就公司最近五年是否 被证券监管部门和证券交易所处罚或采取监管措施的情况披露如下: 一、公司最近五年被证券监管部门和证券交易所处罚情况 经自查,公司最近五年内不存在被证券监管部门和证券交易所处罚的情况。 二、公司最近五年被证券监管部门和交易所采取监管措施及整改情况 于对江西沃格光电股份有限公司和时任董事会秘书万兵予以监管关注的决定》 (上证公监函〔2020〕0051 号) (1)主要问题 公司具备年产 1 亿片的产能。2020 年 1 月 8 日早间、1 月 9 日晚间,公司在 E 互动中回复投资者提问称,"一加手机潜隐式后摄技术-电致变色技术公司全程 参与,主要工艺工程技术由公司研发。 ...
ST逸飞: 逸飞激光关于收到湖北证监局警示函的公告
Zheng Quan Zhi Xing· 2025-05-30 10:41
Core Viewpoint - Wuhan Yifei Laser Co., Ltd. received a warning letter from the Hubei Securities Regulatory Bureau due to significant discrepancies in its financial disclosures, particularly in its annual report and performance announcement [1][2]. Group 1: Violation Details - The company reported a net profit attributable to shareholders of 24.32 million yuan, a decrease compared to the previous year's net profit of 45.315 million yuan [1]. - The company corrected its 2024 annual report, revealing an operating income of 692.0687 million yuan, a net profit of 24.32 million yuan, and a net profit of 9.4123 million yuan after deducting non-recurring gains and losses [1]. Group 2: Regulatory Actions - The company's actions violated the "Administrative Measures for Information Disclosure of Listed Companies," specifically Articles 3 and 17 [2]. - Key executives, including the chairman and general manager, the financial director, and the board secretary, were held primarily responsible for the violations [2]. - The Hubei Securities Regulatory Bureau decided to issue a warning letter and record it in the securities and futures market integrity file [2]. Group 3: Company Response - The company and responsible personnel acknowledged the warning and committed to learning from the issues raised, enhancing compliance with relevant laws and regulations, and improving the quality of information disclosure [2].
嘉应制药遭证监会立案调查,直指公司内控!
IPO日报· 2025-05-30 10:17
星标 ★ IPO日报 精彩文章第一时间推送 5月28日晚间,老牌药企广东嘉应制药股份有限公司(002198.SZ,下称"嘉应制药")发布公告,公司于年5月28日收到证监会《立案告知书》, 因涉嫌信息披露违法违规被正式立案。 公司2025年4月26日发布的《内部控制自我评价报告》显示,众华会计师事务所对其出具了带强调事项段的无保留意见。 具体来看,2024年9月至2025年1月,全资子公司嘉应湖南向关联方湖南药聚能医药有限公司(实控人为董事长李能)累计转出资金1.7亿元,另向 非关联方转资6500万元。 为掩盖痕迹,资金采用"月初转出、月末归还"操作,使各月末账面余额归零,规避审计核查。 该行为未经董事会审批及披露,直至2025年1月23 日才全部归还。 制图:佘诗婕 截至5月29日收盘,公司股价大跌7.46%,市值单日蒸发超2亿元。5月30日,继续小跌0.48%。 公开信息显示,嘉应制药成立于2003年3月,是集研发、生产、销售为一体的中成药制药企业,于2007年12月在深交所挂牌上市。 业绩方面,截至2024年12月31日,公司实现营收3.76亿元,同比下降29.46%;归母净利润为2061万元,同比下降3 ...
际华集团: 际华集团2024年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-30 09:10
Core Points - The company is preparing for the 2024 Annual General Meeting (AGM) scheduled for June 20, 2025, to discuss various proposals including the annual financial report and related transactions [3][4][28] - The company emphasizes the importance of maintaining shareholder rights and orderly conduct during the AGM, with specific guidelines for participation and voting [2][4][5] Group 1: Meeting Procedures - The AGM will be chaired by the company's board chairman, and a secretary will be appointed to manage the meeting procedures [3][4] - Shareholders are required to register their attendance to participate in voting and discussions, with specific rules regarding the validity of votes [2][5] - Legal representatives will be present to witness the meeting and provide legal opinions on the proceedings [2][5] Group 2: Proposals for Discussion - The agenda includes the review of the 2024 Board of Directors' work report, which outlines the company's strategic adjustments and innovations [4][5] - The company plans to discuss the 2024 financial statements, which have been audited and received a standard unqualified opinion from the auditing firm [28] - Proposals will also cover the annual profit distribution plan and the expected amounts for related party transactions for 2024 [20][28] Group 3: Corporate Governance - The company has established a governance structure that includes a board of directors, supervisory board, and various committees to ensure compliance and effective decision-making [6][9] - The board has been active in reviewing and approving significant operational and financial decisions, with a focus on risk management and compliance [7][9] - The company has implemented a comprehensive internal control system to monitor and manage risks effectively [7][26] Group 4: Financial Performance - The company reported its financial results for 2023, highlighting compliance with accounting standards and regulations [19][26] - The financial reports indicate a commitment to transparency and accuracy in financial disclosures, with regular audits conducted [14][26] - The company has outlined its plans for future financial management, including the use of raised funds and investment strategies [20][24]
一周保险速览(5.23—5.30)
Cai Jing Wang· 2025-05-30 08:55
Regulatory Developments - The Financial Regulatory Bureau issued a draft management method for information disclosure of asset management products, aiming to enhance transparency throughout the product lifecycle, ensuring clear understanding of sales, risks, and returns [1] Insurance Industry Trends - The expected reduction in the predetermined interest rate for life insurance may occur as early as the third quarter, following recent decreases in the loan market quotation rate (LPR) and bank deposit rates [2] - The third batch of long-term investment pilot institutions for insurance funds is being approved, including several small and medium-sized insurance companies, marking a new breakthrough in the number and type of participating institutions [3] Investment Activities - Insurance funds accelerated their equity market investments in Q1 2025, increasing stock investments by approximately 390 billion yuan, the largest quarterly increase in recent years, with a stock holding ratio rising to 8.37% [4] - A new equity investment fund, the Ping An Silver Age Equity Investment Fund, was established in Beijing with a capital contribution of 6 billion yuan, focusing on private equity investments and asset management [7] Corporate Actions - Ancheng Insurance announced the unconditional transfer of 18.77% of its shares to Chongqing Development Investment Co., Ltd., with the process of notifying shareholders completed [6] - Ping An Life appointed Shi Weiyu as the new general manager, aiming to enhance corporate governance and drive high-quality development, with the life and health insurance business showing a 5% increase in operating profit year-on-year and a 34.9% increase in new business value [8] Executive Changes - Sheneng Property Insurance has approved two new vice presidents, completing its core management structure with one general manager and four vice presidents, achieving nearly 100 million yuan in net profit in Q1 [9]
嘉应制药被立案信披违规屡教不改 上市18年仅分红5次累计不足9000万
Chang Jiang Shang Bao· 2025-05-29 23:51
一周前,嘉应制药任职10个月的财务总监史俊平辞职。 嘉应制药主要从事中成药的研发、生产和销售,2007年12月登陆A股市场。上市以来,公司经营业绩整 体上不理想。2023年、2024年,公司营收净利双降,今年一季度,公司实现的归属母公司股东的净利润 (以下简称"归母净利润")大增近2倍,但也只有1540万元。 长江商报消息 ●长江商报记者 沈右荣 老牌医药企业嘉应制药(002198.SZ)被立案调查了。 5月28日晚间,嘉应制药公告,当日,公司收到中国证监会的《立案告知书》,因公司涉嫌信息披露违 法违规,证监会决定对公司立案。对于具体所涉何事,嘉应制药在公告中没有提及。 Wind数据显示,上市18年来,嘉应制药累计盈利仅2.75亿元,累计仅进行5次现金分红,累计分红额不 到9000万元。 2024年,嘉应制药研发费用仅为675.72万元,销售费用1.37亿元。 嘉应制药靠什么突围? 信披违规被立案调查 2020年8月,嘉应制药股东承诺12个月内增持不低于5%的股份,在延长12个月后,也仅增持0.16%的股 份,被广东证监局出具警示函,责令整改。当月,控股股东涉及表决权委托事宜,但未并告知嘉应制 药,未予以披露 ...